BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 24438577)

  • 1. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
    Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
    Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.
    Chaillon A; Sirinelli A; De Muret A; Nicand E; d'Alteroche L; Goudeau A
    J Heart Lung Transplant; 2011 Jul; 30(7):841-3. PubMed ID: 21515077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
    Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H
    Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin.
    Junge N; Pischke S; Baumann U; Goldschmidt I; Manns M; Wedemeyer H; Pfister ED
    Pediatr Transplant; 2013 Jun; 17(4):343-7. PubMed ID: 23551547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
    Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
    Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
    Gotanda Y; Iwata A; Ohnuma H; Yoshikawa A; Mizoguchi H; Endo K; Takahashi M; Okamoto H
    J Med Virol; 2007 Jun; 79(6):734-42. PubMed ID: 17457924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
    Rossi-Tamisier M; Moal V; Gerolami R; Colson P
    J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
    Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis E infection in children with liver transplantation.
    Halac U; Béland K; Lapierre P; Patey N; Ward P; Brassard J; Houde A; Alvarez F
    Gut; 2012 Apr; 61(4):597-603. PubMed ID: 22115826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain.
    Mateos-Lindemann ML; Diez-Aguilar M; Galdamez AL; Galán JC; Moreno A; Pérez-Gracia MT
    J Med Virol; 2014 Jan; 86(1):71-4. PubMed ID: 24136591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area.
    Naik A; Gupta N; Goel D; Ippagunta SK; Sharma RK; Aggarwal R
    J Viral Hepat; 2013 Apr; 20(4):e138-40. PubMed ID: 23490383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past and current hepatitis E virus infection in renal transplant patients.
    Hering T; Passos AM; Perez RM; Bilar J; Fragano D; Granato C; Medina-Pestana JO; Ferraz ML
    J Med Virol; 2014 Jun; 86(6):948-53. PubMed ID: 24619955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.